Pharmacological interventions for the treatment of psychological distress in patients with asthma: a systematic review and meta-analysis

References

• Boulet LP. Influence of comorbid conditions on asthma. Eur Respir J. 2009;33(4):897–906. doi:10.1183/09031936.00121308.
   PubMed Web of Science ®Google Scholar
• Katon WJ, Richardson L, Lozano P, McCauley E. The relationship of asthma and anxiety disorders. Psychosom Med. 2004;66(3):349–355. doi:10.1097/01.psy.0000126202.89941.ea.
   PubMed Web of Science ®Google Scholar
• Adams RJ, Wilson DH, Taylor AW, Daly A, Tursan d’Espaignet E, Dal GE, Ruffin R. Psychological factors and asthma quality of life: a population based study. Thorax. 2004;59(11):930–935. doi:10.1136/thx.2003.010256.
   PubMed Web of Science ®Google Scholar
• Katon W, Lozano P, Russo J, McCauley E, Richardson L, Bush T. The prevalence of DSM-IV anxiety and depressive disorders in youth with asthma compared with controls. J Adolesc Health. 2007;41(5):455–463. doi:10.1016/j.jadohealth.2007.05.023.
   PubMed Web of Science ®Google Scholar
• Goodwin RD, Messineo K, Bregante A, Hoven CW, Kairam R. Prevalence of probable mental disorders among pediatric asthma patients in an inner-city clinic. J Asthma. 2005;42(8):643–647. doi:10.1080/02770900500264770.
   PubMed Web of Science ®Google Scholar
• Weiser EB. The prevalence of anxiety disorders among adults with asthma: a meta-analytic review. J Clin Psychol Med Settings. 2007;14(4):297–307. doi:10.1007/s10880-007-9087-2.
   Web of Science ®Google Scholar
• Heaney LG, Conway E, Kelly C, Gamble J. Prevalence of psychiatric morbidity in a difficult asthma population: relationship to asthma outcome. Respir Med. 2005;99(9):1152–1159. doi:10.1016/j.rmed.2005.02.013.
   PubMed Web of Science ®Google Scholar
• Ciprandi G, Schiavetti I, Rindone E, Ricciardolo FL. The impact of anxiety and depression on outpatients with asthma. Ann Allergy Asthma Immunol. 2015;115(5):408–414. doi:10.1016/j.anai.2015.08.007.
   PubMed Web of Science ®Google Scholar
• Vermeire PA, Rabe KF, Soriano JB, Maier WC. Asthma control and differences in management practices across seven European countries. Respir Med. 2002;96(3):142–149. doi:10.1053/rmed.2001.1241.
   PubMed Web of Science ®Google Scholar
• Grzeskowiak LE, Smith B, Roy A, Schubert KO, Baune BT, Dekker GA, Clifton VL. Impact of a history of maternal depression and anxiety on asthma control during pregnancy. J Asthma. 2017;54(7):706–713. doi:10.1080/02770903.2016.1258080.
   PubMed Web of Science ®Google Scholar
• Lavoie KL, Cartier A, Labrecque M, Bacon SL, Lemière C, Malo J-L, Lacoste G, Barone S, Verrier P, Ditto B, et al. Are psychiatric disorders associated with worse asthma control and quality of life in asthma patients?. Respir Med. 2005;99(10):1249–1257. doi:10.1016/j.rmed.2005.03.003.
   PubMed Web of Science ®Google Scholar
• Goldney RD, Ruffin R, Fisher LJ, Wilson DH. Asthma symptoms associated with depression and lower quality of life: a population survey. Med J Aust. 2003;178(9):437–441. doi:10.5694/j.1326-5377.2003.tb05285.x.
   PubMed Web of Science ®Google Scholar
• Nguyen HV, Nadkarni NV, Sankari U, Mital S, Lye WK, Tan NC. Association between asthma control and asthma cost: Results from a longitudinal study in a primary care setting. Respirology. 2017;22(3):454–459. doi:10.1111/resp.12930.
   PubMed Web of Science ®Google Scholar
• Thomas M, Bruton A, Moffat M, Cleland J. Asthma and psychological dysfunction. Prim Care Respir J. 2011;20(3):250–256. doi:10.4104/pcrj.2011.00058.
   PubMedGoogle Scholar
• Chida Y, Hamer M, Steptoe A. A bidirectional relationship between psychosocial factors and atopic disorders: a systematic review and meta-analysis. Psychosom Med. 2008;70(1):102–116. doi:10.1097/PSY.0b013e31815c1b71.
   PubMed Web of Science ®Google Scholar
• Tibosch MM, Verhaak CM, Merkus PJ. Psychological characteristics associated with the onset and course of asthma in children and adolescents: a systematic review of longitudinal effects. Patient Educ Couns. 2011;82(1):11–19. doi:10.1016/j.pec.2010.03.011.
   PubMed Web of Science ®Google Scholar
• Merghani TH, Alawad AO. Indicators of Asthma Control in Asthmatic Patients: Are they related to Depression? Open Access Maced. J Med Sci. 2017;5(5):673–676. doi:10.3889/oamjms.2017.091.
   Google Scholar
• Cassano GB, Baldini Rossi N, Pini S. Psychopharmacology of anxiety disorders. Dialogues Clin Neurosci. 2002;4(3):271–285.
   PubMedGoogle Scholar
• Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47–53. doi:10.1001/jama.2009.1943.
   PubMed Web of Science ®Google Scholar
• Sanger MD. The treatment of anxiety and depression in the allergic patient. Ann Allergy. 1969;27(10):506–510.
   PubMedGoogle Scholar
• Sugihara H, Ishihara K, Noguchi H. Clinical experience with amitriptyline (tryptanol) in the treatment of bronchial asthma. Ann Allergy. 1965;23(9):422–429.
   PubMedGoogle Scholar
• Castanon N, Leonard BE, Neveu PJ, Yirmiya R. Effects of antidepressants on cytokine production and actions. Brain Behav Immun. 2002;16(5):569–574. doi:10.1016/S0889-1591(02)00008-9.
   PubMed Web of Science ®Google Scholar
• Frieri M. Neuroimmunology and inflammation: implications for therapy of allergic and autoimmune diseases. Ann Allergy Asthma Immunol. 2003;90(6):34–40. doi:10.1016/S1081-1206(10)61658-4.
   PubMed Web of Science ®Google Scholar
• Whittington CJ, Kendall T, Fonagy P, Cottrell D, Cotgrove A, Boddington E. Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data. Lancet. 2004;363(9418):1341–1345. doi:10.1016/S0140-6736(04)16043-1.
   PubMed Web of Science ®Google Scholar
• Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention 2018. Available at: http://www.ginasthma.org/. Accessed 10 December 2018.
   Google Scholar
• National Asthma Council Australia. Australian Asthma Handbook, Version 1.2. 2016. Available at: http://www.asthmahandbook.org.au. Accessed 10 December 2018.
   Google Scholar
• Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8(5):336–341. doi:10.1016/j.ijsu.2010.02.007.
   PubMed Web of Science ®Google Scholar
• Higgins J, Green S. Cochrane Handbook for systematic Reviews of Interventions Version 5.1.0. [updated March 2011]. London, UK: The Cochrane Collaboration; 2011.
   Google Scholar
• Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, Schünemann HJ. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Bmj. 2008;336(7650):924–926. doi:10.1136/bmj.39489.470347.AD.
   PubMed Web of Science ®Google Scholar
• Brown ES, Khan DA, Vigil L, Liggin JDM, Carmody TJ, Rush AJ. A randomized, double-blind, placebo-controlled trial of citalopram in outpatient adults with asthma and major depressive disorder. Biol Psychiatry. 2005;57(8):118S–118S.
   Web of Science ®Google Scholar
• Brown ES, Howard C, Khan DA, Carmody TJ. Escitalopram for severe asthma and major depressive disorder: a randomized, double-blind, placebo-controlled proof-of-concept study. Psychosomatics. 2012;53(1):75–80. doi:10.1016/j.psym.2011.07.009.
   PubMed Web of Science ®Google Scholar
• Brown ES, Sayed N, Van Enkevort E, Kulikova A, Nakamura A, Khan DA, Ivleva EI, Sunderajan P, Bender BG, Holmes T, et al. A randomized, double-blind, placebo-controlled trial of escitalopram in patients with asthma and major depressive disorder. J Allergy Clin Immunol Pract. 2018;6(5):1604–1612. doi:10.1016/j.jaip.2018.01.010.
   PubMed Web of Science ®Google Scholar
• Abdulghani Mohamad A, Mg A, Amina Hamed Ahmed A. Evaluation of the therapeutic effect of combined conventional asthma drugs with tianeptine in treatment of asthma —double-blind controlled trial pilot study. In Evidence-based Strategies in Herbal Medicine, Psychiatric Disorders and Emergency Medicine. London: IntechOpen; 2014
   Google Scholar
• Brown E, Frol AB, Khan DA, Larkin GL, Bret ME. Impact of levetiracetam on mood and cognition during prednisone therapy. Eur. Psychiatry. 2007;22(7):448–452. doi:10.1016/j.eurpsy.2007.06.002.
   PubMed Web of Science ®Google Scholar
• Lechin F, van der Dijs B, Lechin AE. Treatment of bronchial asthma with tianeptine. Methods Find Exp Clin Pharmacol. 2004;26(9):697–701. doi:10.1358/mf.2004.26.9.872567.
   PubMedGoogle Scholar
• McEwen BS, Chattarji S, Diamond DM, Jay TM, Reagan LP, Svenningsson P, Fuchs E. The neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulation. Mol Psychiatry. 2010;15(3):237–249. doi:10.1038/mp.2009.80.
   PubMed Web of Science ®Google Scholar
• Rayner L, Price A, Evans A, Valsraj K, Higginson IJ, Hotopf M. Antidepressants for depression in physically ill people. Cochrane Database Syst Rev. 2010;3:CD007503.
   Google Scholar
• Taylor D, Meader N, Bird V, Pilling S, Creed F, Goldberg D. Pharmacological interventions for people with depression and chronic physical health problems: systematic review and meta-analyses of safety and efficacy. Br J Psychiatry. 2011;198(3):179–188. doi:10.1192/bjp.bp.110.077610.
   PubMed Web of Science ®Google Scholar
• Yorke J, Fleming SL, Shuldham C. Psychological interventions for adults with asthma: a systematic review. Respir Med. 2007;101(1):1–14. doi:10.1016/j.rmed.2006.04.003.
   PubMed Web of Science ®Google Scholar
• Thomas M, Price D. Impact of comorbidities on asthma. Expert Rev Clin Immunol. 2008;4(6):731–742. doi:10.1586/1744666X.4.6.731.
   PubMed Web of Science ®Google Scholar
• Kopschina Feltes P, Doorduin J, Klein HC, Juárez-Orozco LE, Dierckx RA, Moriguchi-Jeckel CM, de Vries EF. Anti-inflammatory treatment for major depressive disorder: implications for patients with an elevated immune profile and non-responders to standard antidepressant therapy. J Psychopharmacol. 2017;31(9):1149–1165. doi:10.1177/0269881117711708.
   PubMed Web of Science ®Google Scholar
• Roumestan C, Michel A, Bichon F, Portet K, Detoc M, Henriquet C, Jaffuel D, Mathieu M. Anti-inflammatory properties of desipramine and fluoxetine. Respir Res. 2007;8(1):35. doi:10.1186/1465-9921-8-35.
   PubMed Web of Science ®Google Scholar
• Qu J, Li Y, Zhong W, Gao P, Hu C. Recent developments in the role of reactive oxygen species in allergic asthma. J Thorac Dis. 2017;9(1):E32–E43. doi:10.21037/jtd.2017.01.05.
   PubMed Web of Science ®Google Scholar
• Brown ES, Rush AJ, McEwen BS. Hippocampal remodeling and damage by corticosteroids: implications for mood disorders. Neuropsychopharmacology. 1999;21(4):474–484. doi:10.1016/S0893-133X(99)00054-8.
   PubMed Web of Science ®Google Scholar
• Martin LA, Neighbors HW, Griffith DM. The experience of symptoms of depression in men vs women: analysis of the National Comorbidity Survey Replication. JAMA Psychiatry. 2013;70(10):1100–1106. doi:10.1001/jamapsychiatry.2013.1985.
   PubMed Web of Science ®Google Scholar
• Remes O, Brayne C, van der Linde R, Lafortune L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav. 2016;6(7):e00497. doi:10.1002/brb3.497.
   PubMed Web of Science ®Google Scholar
• Vuillermin PJ, Brennan SL, Robertson CF, Carlin JB, Prior M, Jenner BM, South M. Anxiety is more common in children with asthma. Arch Dis Child. 2010;95(8):624–629. doi:10.1136/adc.2009.166967.
   PubMed Web of Science ®Google Scholar
• Bush A, Saglani S. Management of severe asthma in children. Lancet. 2010;376(9743):814–825. doi:10.1016/S0140-6736(10)61054-9.
   PubMed Web of Science ®Google Scholar